Bernard H. Paul - Jan 14, 2022 Form 3 Insider Report for Acer Therapeutics Inc. (ACER)

Role
Chief People Officer
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Stock symbol
ACER
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
3
Date filed
1/21/2022, 03:04 PM
Next filing
Mar 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACER Employee Stock Option (right to buy) Jan 14, 2022 Common Stock 25K $19.35 Direct F1
holding ACER Employee Stock Option (right to buy) Jan 14, 2022 Common Stock 30K $3.42 Direct F2
holding ACER Employee Stock Option (right to buy) Jan 14, 2022 Common Stock 10K $3.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable over four years as follows: 25% of the shares vest on the one-year anniversary of the grant date, and the remaining 75% of the shares vest quarterly over the remaining three years.
F2 The option vests and becomes exercisable over two years as follows: 50% on 01/01/2021 and 50% on 01/01/2022.

Remarks:

Exhibit List: Exhibit 24 - Confirming Statement